Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $71.20 Consensus Target Price from Analysts
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have received a consensus rating of “Buy” from the seven brokerages that are covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 12 […]
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have received a consensus rating of “Buy” from the seven brokerages that are covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 12 […]
